News

WE ARE ATTENDING MAKING PHARMACEUTICALS IN MILAN 2023

PHARMADULE HOSTS CONFERENCE IN EGYPT

Together with our partners in Egypt, United Group and EIPICO, Pharmadule is arranging a 1-day conference i Cairo around the...

GREAT SUCCESS AT THE ACHEMA EXHIBITION IN FRANKFURT

Originally planned for June 2020, the Achema exhibition in Frankfurt, Germany could finally be held in August 2022 due to...

BIOLOGICALS & BIOSIMILARS MANUFACTURING FACILITY TO EGYPT

Pharmadule Morimatsu will deliver a modular turn-key facility to Egyptian International Pharmaceutical Industries, EIPICO,...

SHIPPING MODULAR VACCINE PLANT TO MOROCCO

Pharmadule Morimatsu has completed and shipped a turn-key modular vaccine facility to Morocco, Africa. The facility consists...

mRNA VACCINE PRODUCTION PLANT IN 7.5 MONTHS - MAKING A DIFFERENCE

Pharmadule Morimatsu has successfully completed the first SARS CoV-2 mRNA vaccine production plant to Chinese vaccine manufacturer...

PHARMADULE MORIMATSU EXPANDS - INTRODUCING MORIMATSU ITALY

Pharmadule Morimatsu expands the operation by opening an office in Milan, Italy. The Italian office will serve as a hub for...

MORIMATSU INTERNATIONAL OFFICIALLY LISTED ON THE HONG KONG STOCK EXCHANGE

On the afternoon of 28 June 2021, Morimatsu International Holdings Ltd. (hereinafter as “Morimatsu International”) was officially...

PHARMADULE MORIMATSU OPENS NEW OFFICE IN NEW JERSEY, USA

PHARMADULE MORIMATSU COMPLETED THE SETTING OF KUBIO MODULES FOR GE FIT-OUT OF THE LONZA BIOLOGICS FACILITY IN GUANGZHOU

On the December 12th 2019, with the last six modules being lift and placed within one day, 54 modules designed and fabricated...